Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL40065

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)SCc1ccco1

Basic Information

ChEMBL ID CHEMBL40065
Phase Preclinical
Structure Type MOL
InChI Key PZFYXVJBUZGUQW-DOFZRALJSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names

Molecular Properties

400.6
MW (Da)
8.19
ALogP
3
HBA
0
HBD
30.2
PSA (Ų)
0.21
QED
1
Ro5 Violations
16
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C25H36O2S
MW 400.63
Aromatic Rings 1
Heavy Atoms 28
NP-Likeness 0.29

Activity Summary

IC50 1 meas. best 5.05

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Homo sapiens
CHEMBL372
IC50 5.05 5.05 9000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Homo sapiens IC50 = 9000.0 nM 5.05 Inhibition of [3H]anandamide transport(ANT) in human lymphoma U937 cell 12672252

Literature References

PubMed DOI Target Context # Activities
12672252 10.1021/jm0210818 Homo sapiens 2
12672252 10.1021/jm0210818 Fatty-acid amide hydrolase 1 2
12672252 10.1021/jm0210818 Cannabinoid receptor 1 1
12672252 10.1021/jm0210818 Cannabinoid receptor 2 1
12672252 10.1021/jm0210818 Transient receptor potential cation channel subfamily V member 1 1

Data from ChEMBL 36 via Core Engine